Abbott Laboratories (Pakistan) (KAR:ABOT) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:ABOT Abbott Laboratories (Pakistan) Ltd KAR:ABOT
73 GF Score
Price ₨923.72
GF Value ₨1,027.53
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Abbott Laboratories (Pakistan) Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Abbott Laboratories (Pakistan)  (KAR:ABOT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Abbott Laboratories (Pakistan) Cyclically Adjusted PB Ratio Related Terms


Abbott Laboratories (Pakistan) Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories (Pakistan)'s Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories (Pakistan) Cyclically Adjusted PB Ratio Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.91 2.82 2.61 6.48 4.99

Abbott Laboratories (Pakistan) Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.13 6.51 5.33 4.32 4.66

KAR:ABOT vs ZTS, UTHR: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories (Pakistan) Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s Cyclically Adjusted PB Ratio falls into.


KAR:ABOT
73GF Score
Abbott Laboratories (Pakistan) Ltd KAR:ABOT
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories (Pakistan) Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Abbott Laboratories (Pakistan)'s Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Abbott Laboratories (Pakistan)'s adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=327.85/333.9520*333.9520
=327.850

Current CPI (Jun. 2026) = 333.9520.

Abbott Laboratories (Pakistan) Quarterly Data

Book Value per Share CPI Adj_Book
201609 131.592 241.428 182.023
201612 149.062 241.432 206.185
201703 156.378 243.801 214.202
201706 136.436 244.955 186.006
201709 137.897 246.819 186.578
201712 146.637 246.524 198.641
201803 123.149 249.554 164.797
201806 129.805 251.989 172.026
201809 128.359 252.439 169.806
201812 135.189 251.233 179.700
201903 128.799 254.202 169.207
201906 130.953 256.143 170.733
201909 134.012 256.759 174.302
201912 136.592 256.974 177.509
202003 138.196 258.115 178.799
202006 151.334 257.797 196.039
202009 146.694 260.280 188.216
202012 159.246 260.474 204.168
202103 149.276 264.877 188.204
202106 168.355 271.696 206.932
202109 161.060 274.310 196.079
202112 177.268 278.802 212.333
202203 172.375 287.504 200.223
202206 176.250 296.311 198.639
202209 169.758 296.808 191.002
202212 174.729 296.797 196.603
202303 173.178 301.836 191.605
202306 167.944 305.109 183.820
202309 168.718 307.789 183.060
202312 186.285 306.746 202.807
202403 202.641 312.332 216.668
202406 209.817 314.175 223.025
202409 229.127 315.301 242.681
202412 242.335 315.605 256.423
202503 249.423 319.799 260.461
202506 270.031 322.561 279.567
202509 289.630 324.800 297.791
202512 323.037 324.054 332.904
202603 344.095 330.213 347.991
202606 327.850 333.952 327.850

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Abbott Laboratories (Pakistan) (KAR:ABOT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) stock appears to be undervalued. The current stock price of ₨923.72 is trading 10.1% below its estimated GF Value™ of ₨1,027.53. GuruFocus considers Abbott Laboratories (Pakistan) to be Modestly Undervalued.

Key valuation signals for KAR:ABOT:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₨1,027.53 vs. price of ₨923.72 (10.1% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the KAR:ABOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories (Pakistan) Business Description

Address Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. The company's Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
73GF Score

Get the complete analysis for KAR:ABOT

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨923.72
Price
₨1,027.53
GF Value